Market Value3,566,983,000
Total Holdings69
File Date2020-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AKRO / Akero Therapeutics, Inc.
TNDM / Tandem Diabetes Care, Inc.
RVMD / Revolution Medicines, Inc.
CNC / Centene Corporation
CABA / Cabaletta Bio, Inc.
TCRR / Tcr2 Therapeutics Inc
QURE / uniQure N.V.
PTCT / PTC Therapeutics, Inc.
AMED / Amedisys, Inc.
BOLD / Boundless Bio, Inc.
FATE / Fate Therapeutics, Inc.
GH / Guardant Health, Inc.
CYRX / Cryoport, Inc.
OVID / Ovid Therapeutics Inc.
PPD / PPD Inc
ODT / Odonate Therapeutics Inc
GLYC / GlycoMimetics, Inc.
GTHX / G1 Therapeutics, Inc.
US29266S3040 / Endologix, Inc.
US74257L1089 / Principia Biopharma Inc.
MRK / Merck & Co., Inc.
GOSS / Gossamer Bio, Inc.
CSLT / Castlight Health Inc - Class B
NVRO / Nevro Corp.
TWST / Twist Bioscience Corporation
US60877T1007 / Momenta Pharmaceuticals, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
FOLD / Amicus Therapeutics, Inc.
BIIB / Biogen Inc.
SYRS / Syros Pharmaceuticals, Inc.
VAPO / Vapotherm, Inc.
US69354M1080 / PRA Health Sciences Inc
AXNX / Axonics, Inc.
PROF / Profound Medical Corp.
US28249H1041 / Eidos Therapeutics, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
ONEM / 1life Healthcare Inc
HCA / HCA Healthcare, Inc.
CI / The Cigna Group
PAYX / Paychex, Inc.
EPZM / Epizyme Inc
GMXAY / Genmab A/S
ADPT / Adaptive Biotechnologies Corporation
FTSV / Forty Seven, Inc.
CLVS / Clovis Oncology Inc
NLTX / Neoleukin Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
UNH / UnitedHealth Group Incorporated
SGEN / Seagen Inc
SWAV / Shockwave Medical, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
ZYME / Zymeworks Inc.
WVE / Wave Life Sciences Ltd.
CBAY / CymaBay Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
REPL / Replimune Group, Inc.
KRYS / Krystal Biotech, Inc.
STOK / Stoke Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
ALLK / Allakos Inc.
IMGN / ImmunoGen, Inc.
XERS / Xeris Biopharma Holdings, Inc.
HOOK / HOOKIPA Pharma Inc.
BSX / Boston Scientific Corporation
ELV / Elevance Health, Inc.
BEAM / Beam Therapeutics Inc.
RGNX / REGENXBIO Inc.
CTLT / Catalent, Inc.
ARDX / Ardelyx, Inc.
STXS / Stereotaxis, Inc.
BCEL / Atreca, Inc.
ATRA / Atara Biotherapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
IGMS / IGM Biosciences, Inc.
GRTSQ / Gritstone bio, Inc.